Healthcare -
Medical - Devices - NASDAQ - US
$ 1.34
-9.46 %
$ 79.5 M
Market Cap
-1.2
P/E
Price Target
Average
99.00%
Revenue Forecast
Estimate
174.83%
EBIT
Estimate
40.76%
Net Income
Estimate
32.38%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Lucid Diagnostics Inc.
Wall Street analysts predict an average 1-year price target for LUCD of $2.67 , with forecasts ranging from
a
low of
$2.5 to a high of $3 .
LUCD Lowest Price Target
Wall Street Target
2.5 USD
86.57%
LUCD Average Price Target
Wall Street Target
2.67 USD
99.00%
LUCD Highest Price Target
Wall Street Target
3 USD
123.88%
REVENUE FORECAST
Revenue Forecast Chart LUCD
EBIT FORECAST
EBIT Forecast Chart LUCD
NET INCOME FORECAST
Net Income Chart LUCD